Clinical Trial: Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia (Phase 1: Open-label, Dose-escalation, Single-center ; Phase2: Randomized, Double-blind, Placebo-controlled, Multi-center)

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07808905) titled 'Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia (Phase 1: Open-label, Dose-escalation, Single-center ; Phase2: Randomized, Double-blind, Placebo-controlled, Multi-center)' on Sept. 02.

Brief Summary: A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of EN001 in Patients with Sarcopenia

Study Start Date: March 01, 2027

Study Type: INTERVENTIONAL

Condition: Sarcopenia

Intervention: DRUG: EN001

- Phase1-Cohort 1: EN001 Low dose administered intravenously (IV) 3 times at 4 week intervals.

DRUG: EN001

-Phase2-Cohort 2 : EN001 Medium d...